Aurobindo Pharma gets FDA approval for generic equivalent of Xarelto
The anticoagulant drug, which has an estimated US market size of $447 million, is set to be launched in the first quarter of the 2025-26 fiscal.
13 April, 2025•2 min
0
13 April, 2025•2 min
0
More in Business
Business
The weight-loss wave that’s changing India—one sector at a time
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
You may also like
Business
Has Aurobindo Pharma left its wild swings behind?
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.
Business
Is Aurobindo Pharma the most underrated pharma company?
The Hyderabad-based generics maker is now India’s largest supplier of off-patent medicines to the US.